title: Guillian-Barre syndrome as the initial presentation of systemic lupus erythematosus--case report and review of literature.
abstract: A number of neurological entities have been associated with systemic lupus erythematosus (SLE). Gullian-Barre syndrome (GBS) as a presenting feature of SLE remains uncommon with just 9 cases reported in the last half-century with the first case reported in 19641-9 (Table 1). We report a young female presenting with GBS in whom SLE and WHO class V lupus nephritis (LN) was subsequently diagnosed. The neurological symptoms partially responded to pulse methylprednisone, intravenous immunoglobulin (IVIG) and plasmapheresis.
authors.affiliation: Quaid Johar Nadri, MD, MBC 46 Department of Medicine, King Faisal Specialist Hospital and Research Centre,, PO Box 3354 Riyadh 11211, Saudi Arabia, T: 966-11-442-7492 F: 966-11-442-7499, qnadri@kfshrc.edu.sa.
authors.forename: Quaid
authors.initials: Q
authors.lastname: Nadri
authors.forename: Mohammed Mahdi
authors.initials: MM
authors.lastname: Althaf
mesh_terms: D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D020275:Guillain-Barre Syndrome / Q000150:complications* / Q000628:therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000473:pathology; D008181:Lupus Nephritis / Q000209:etiology; D008775:Methylprednisolone / Q000627:therapeutic use; D010956:Plasmapheresis; D012529:Saudi Arabia; D055815:Young Adult
chemical_list: D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D008775:Methylprednisolone